Emerging California Medical Device Company, GraftWorx, Wins Preclinical In-Kind Services from Surpass as Part of the Rosenman Institute's 2015 Innovation Award...Continue Reading
Surpass CEO Dr. Tim Pelura provides a guest blog on MDTmag outlining the importance of value-driven innovation and how to construct a value proposition for medical technologies. The July 21, 2015, edition of MDTmag, the online Medical Design Technology news source, featured Does Your Medical Innovation Have Legs in the New Healthcare Reality...Continue Reading
Surpass, Inc., a recognized leader in preclinical research services for the medical device industry, announced it is sponsoring the Rosenman Institute's Innovation Awards this year. The Rosenman Institute, an initiative of California life science accelerator, QB3, speeds the development of medical devices...Continue Reading
Surpass, Inc., a leading preclinical contract research organization (CRO) servicing the medical device, pharma, and biotech industries received CRO Leadership Awards by Life Science Leader Magazine for the second year in a row in the areas of quality and regulatory...Continue Reading
Preclinical Research Leader, SURPASS Establishes a Surpass Innovation Award at the University of Minnesota Medical Devices Center to Support Early-Stage Medtech Entrepreneurs and Medical Device Innovation...Continue Reading
Preclinical Research Leader, SURPASS Establishes the Surpass Innovation Award to Support Early-Stage Medtech Innovation and Researchers within University of California, San Francisco's, Clinical and Translational Science Institute... Continue Reading
Preclinical Research Leader, SURPASS Establishes the Surpass Award in Support of Early Stage Medical Innovation and Entrepreneurs within the Stanford Biodesign Program... Continue Reading
Preclinical research leader, Surpass, launches new company logo and corporate website signaling a transformation of preclinical culture as an integrated innovation partner for clients in the life science community... Continue Reading
Preclinical research leader, Surpass, announced the recent addition of David Craig and Benigno Mills to the Surpass-Silicon Valley team and the launch of additional social media accounts... Continue Reading
Preclinical Research Leader, Surpass, Receives CRO Leadership Awards in Quality, Innovation, Reliability, Productivity, and Regulatory. March 13, 2014, Osceola, WI and Mountain View, CA - Surpass, Inc. ("Surpass"), a recognized leader in preclinical research, announced that it has received CRO Leadership Awards in the following categories: Quality, Innovation, Reliability, Productivity, and Regulatory. The awards are given by Life Science Leader Magazine based on industry research conducted by Nice Insight which includes feedback from customers that use the CRO Services… Continue Reading
Veteran Executive with Proven Medical Device, Pharmaceutical, and Biotech Industry Experience Joins Surpass. December 16, 2013, Osceola, WI and Mountain View, CA - Surpass, Inc. ("Surpass"), a recognized leader in preclinical research, announced today the appointment of Tim Pelura, PhD as Surpass' President and Chief Executive Officer effective on December 16, 2013. Dr. Pelura is a serial life science entrepreneur and executive with more than 35 years of experience in pharmaceutical, biotech and medical device industries and has been pivotal in the development of several new drugs spanning numerous therapeutic areas… Continue Reading
Surpass-Silicon Valley has acquired a St. Jude En-Site Velocity TM Mapping System that can be used on electrophysiology studies for cardiac mapping and navigation. Contact us today to learn more.
Surpass and Surpass-Silicon Valley, LLC (formerly LyChron, LLC) to offer premier preclinical research services, accelerating progress along the product development pipeline. January 17, 2013, Osceola, WI - Surpass, Inc. ("Surpass") announced today the acquisition of LyChron, LLC ("LyChron"), expanding its capacity to serve the medical device and preclinical research community. The new California entity will operate as Surpass-Silicon Valley, LLC… Continue Reading
Sign up to receive Surpass' newsletter,
the Surpass Insight.